OncoMyx Therapeutics Company
OncoMyx Therapeutics develops oncolytic immunotherapies to orchestrate an immune response and treat cancer.
Employee Number:
1-10
Funding Status:
Early Stage Venture
Headquarters:
Tempe, Arizona, United States
Technology:
Immunotherapy
Estimated Revenue:
$1M to $10M
Founded Date:
2018
Industry:
PharmTech